Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |